Neuroprotection by Association of Palmitoylethanolamide with Luteolin in Experimental Alzheimer’s Disease Models: The Control of Neuroinflammation

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|13|9|1530-1541

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.13, Iss.9, 2014-11, pp. : 1530-1541

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Association of Palmitoylethanolamide with Luteolin Decreases Neuroinflammation and Stimulates Autophagy in Parkinson’s Disease Model

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 10, 2015-12 ,pp. : 1350-1366

Bentham Science Publishers

Access to resources Recommend Favorite

Oestrogen and nerve growth factor – neuroprotection and repair in Alzheimer’s disease

By Granholm A-C.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 4, 2000-04 ,pp. : 685-694

Informa Healthcare

Access to resources Recommend Favorite

Neuroglial Roots of Neurodegenerative Diseases: Therapeutic Potential of Palmitoylethanolamide in Models of Alzheimer's Disease

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 1, 2013-02 ,pp. : 62-69

Bentham Science Publishers

Access to resources Recommend Favorite

Cytokines in Neuroinflammation and Alzheimer's Disease

By  

Current Drug Targets, Vol. 5, Iss. 6, 2004-08 ,pp. : 529-534

Bentham Science Publishers

Access to resources Recommend Favorite

Reactive Oxygen Species, Redox Signaling and Neuroinflammation in Alzheimer's Disease: The NF-&kgr;B Connection

By  

Current Topics in Medicinal Chemistry, Vol. 15, Iss. 5, 2015-03 ,pp. : 446-457

Bentham Science Publishers

Access to resources Recommend Favorite